The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 50,136,726 | 2,405,793 | SH | SOLE | 2,405,793 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,074,144 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 17,007,851 | 55,705 | SH | SOLE | 55,705 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 16,901,234 | 603,400 | SH | SOLE | 603,400 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 127,972,108 | 10,524,022 | SH | SOLE | 10,524,022 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 7,744,783 | 431,224 | SH | SOLE | 431,224 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 97,993,287 | 381,282 | SH | SOLE | 381,282 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 162,009,977 | 1,831,035 | SH | SOLE | 1,831,035 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 3,291,183 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 20,271,405 | 2,739,379 | SH | SOLE | 2,739,379 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 5,438,424 | 6,530,288 | SH | SOLE | 6,530,288 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 148,709,648 | 5,889,491 | SH | SOLE | 5,889,491 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 7,605,674 | 5,675,876 | SH | SOLE | 5,675,876 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 780,878 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,044,520 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 7,434,911 | 386,832 | SH | SOLE | 386,832 | 0 | 0 | ||
NOVOCURE LTD | COM | G6674U108 | 10,663,441 | 660,275 | SH | SOLE | 660,275 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 79,972,349 | 1,657,458 | SH | SOLE | 1,657,458 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 2,197,200 | 732,400 | SH | SOLE | 732,400 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 59,972,145 | 5,228,609 | SH | SOLE | 5,228,609 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 20,698,870 | 1,005,776 | SH | SOLE | 1,005,776 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 11,398,317 | 94,030 | SH | SOLE | 94,030 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 55,240,348 | 1,374,822 | SH | SOLE | 1,374,822 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,862,152 | 472,600 | SH | SOLE | 472,600 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 380,755 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,484,657 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 130,080,114 | 575,907 | SH | SOLE | 575,907 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 343,245 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,205,215 | 278,985 | SH | SOLE | 278,985 | 0 | 0 |